All Eyes on D.C. As FDA Begins Hearings on Pharma and Social Media
Hundreds of advertising, marketing and public relations executives have gathered in Washington, D.C. today for FDA public hearings on “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools.” The hearings are just one step in the FDA’s process to develop policy and guidelines for pharmaceutical companies looking to use social media to promote their products.
“What’s happening is these new media are emerging at an increasingly rapid rate, and are being regulated by an agency that moves very slowly…In essence, you have a regulatory communication crisis developing,” attorney Mark Senak, who advises drug companies as a consultant for Fleishman-Hillard, told
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in